Y Zheng, S Luo, M Xu, Q He, J Xie, J Wu… - … Pharmaceutica Sinica B, 2024 - Elsevier
Despite the promising prospects of nanoparticles in oral drug delivery, the process of oral administration involves a complex transportation pathway that includes cellular uptake …
M Wang, R Bergès, A Malfanti, V Préat… - Drug delivery and …, 2024 - Springer
Glioblastoma (GBM) recurrences appear in most cases around the resection cavity borders and arise from residual GBM cells that cannot be removed by surgery. Here, we propose a …
AC Correia, I Costa, R Silva, P Sampaio… - International Journal of …, 2024 - Elsevier
Epilepsy is a highly prevalent neurological disease and valproic acid (VPA) is used as a first- line chronic treatment. However, this drug has poor oral bioavailability, which requires the …
Introduction Diabetes mellitus is one of the challenging health problems worldwide. Multiple daily subcutaneous injection of insulin causes poor compliance in patients. Development of …
S Chaturvedi, A Garg - Journal of Drug Delivery Science and Technology, 2023 - Elsevier
Exemestane (EXE) a potent third generation aromatase inhibitor and is employed as first line treatment in estrogen receptor positive breast cancer. Its oral bioavailability is only 5 …
O Zupančič, M Spoerk, A Paudel - Expert Opinion on Drug Delivery, 2022 - Taylor & Francis
Introduction Self-emulsifying drug delivery systems (SEDDS) are a promising strategy to improve the oral bioavailability of poorly water-soluble drugs (PWSD). However, poor drug …
This study focuses on optimizing the delivery of Nelfinavir (NFV), a vital protease inhibitor in antiretroviral therapy, and Epigallocatechin gallate (EGCG), a potent adjunctive anti-human …
S Shah, V Patel - International Journal of Pharmaceutics, 2023 - Elsevier
The ocular system, unlike any other human body organ, is a system in which foreign bodies appear quite defenceless in front of the eye. Several infections of the ocular system occur …
J Cui, Z Wen, W Zhang, W Wu - Pharmaceuticals, 2022 - mdpi.com
The high physiology and low toxicity of therapeutic peptides and proteins have made them a hot spot for drug development in recent years. However, their poor oral bioavailability and …